Alice Willison

533 total citations
17 papers, 210 citations indexed

About

Alice Willison is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Alice Willison has authored 17 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 5 papers in Oncology. Recurrent topics in Alice Willison's work include Multiple Sclerosis Research Studies (7 papers), Peripheral Neuropathies and Disorders (5 papers) and Cervical and Thoracic Myelopathy (2 papers). Alice Willison is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Peripheral Neuropathies and Disorders (5 papers) and Cervical and Thoracic Myelopathy (2 papers). Alice Willison collaborates with scholars based in Germany, United Kingdom and Australia. Alice Willison's co-authors include Susan C. Barnett, Susan L. Lindsay, Sven G. Meuth, Benjamin M. Davies, Mark Kotter, Hans‐Peter Hartung, Tobias Ruck, Marc Pawlitzki, Barry J. Coull and Anthony J. Chalmers and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Neurology and International Journal of Molecular Sciences.

In The Last Decade

Alice Willison

16 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alice Willison Germany 9 90 45 43 39 35 17 210
Katayoun Alikhani Canada 8 106 1.2× 60 1.3× 98 2.3× 27 0.7× 74 2.1× 15 259
Ann Powers United States 7 52 0.6× 39 0.9× 24 0.6× 35 0.9× 11 0.3× 9 250
Xuejiao Yang China 5 113 1.3× 67 1.5× 15 0.3× 35 0.9× 8 0.2× 10 206
Azza Ismail United Kingdom 10 57 0.6× 65 1.4× 60 1.4× 20 0.5× 140 4.0× 16 268
Swetha J. Sundar United States 10 87 1.0× 64 1.4× 77 1.8× 15 0.4× 21 0.6× 21 323
Frederik Bartels Germany 11 69 0.8× 29 0.6× 31 0.7× 23 0.6× 128 3.7× 18 249
Martin W. Hümmert Germany 7 99 1.1× 56 1.2× 40 0.9× 6 0.2× 64 1.8× 18 244
John L. Gillick United States 8 107 1.2× 95 2.1× 58 1.3× 45 1.2× 20 0.6× 17 334
Gary R. Simonds United States 10 89 1.0× 162 3.6× 63 1.5× 45 1.2× 30 0.9× 17 397
Ide Smets Belgium 10 134 1.5× 52 1.2× 19 0.4× 11 0.3× 71 2.0× 28 303

Countries citing papers authored by Alice Willison

Since Specialization
Citations

This map shows the geographic impact of Alice Willison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Willison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Willison more than expected).

Fields of papers citing papers by Alice Willison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Willison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Willison. The network helps show where Alice Willison may publish in the future.

Co-authorship network of co-authors of Alice Willison

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Willison. A scholar is included among the top collaborators of Alice Willison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Willison. Alice Willison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Winter, Pia, S. Wolff, Alice Willison, et al.. (2025). Association of body mass index and clinical response in patients receiving ofatumumab for treatment of multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 96(8). 802–806. 1 indexed citations
3.
Meuth, Sven G., S. Wolff, Alice Willison, et al.. (2024). Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab. Annals of Neurology. 97(3). 583–595. 4 indexed citations
4.
Willison, Alice, et al.. (2024). SARS-CoV-2 Vaccination and Neuroimmunological Disease. JAMA Neurology. 81(2). 179–179. 11 indexed citations
5.
Nelke, Christopher, Christina B. Schroeter, Frauke Stascheit, et al.. (2023). Eculizumab treatment alters the proteometabolome beyond the inhibition of complement. JCI Insight. 8(13). 5 indexed citations
6.
Pfeuffer, Steffen, Leoni Rolfes, Jens Ingwersen, et al.. (2023). Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab. Neurology Neuroimmunology & Neuroinflammation. 10(3). 4 indexed citations
7.
Brannigan, Jamie, Benjamin M. Davies, Alice Willison, et al.. (2022). Degenerative cervical myelopathy education in UK medical schools: a national cross-sectional survey of medical students. British Journal of Neurosurgery. 36(6). 728–736. 7 indexed citations
8.
Willison, Alice, Tobias Ruck, Georg Lenz, Hans‐Peter Hartung, & Sven G. Meuth. (2022). The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis. Journal of Neurology. 269(7). 3937–3958. 13 indexed citations
9.
Masanneck, Lars, Leoni Rolfes, Alice Willison, et al.. (2022). Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies. Multiple Sclerosis and Related Disorders. 63. 103927–103927. 17 indexed citations
10.
Pawlitzki, Marc, Lars Masanneck, Alice Willison, et al.. (2022). Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019. SHILAP Revista de lepidopterología. 4(1). 62–62. 8 indexed citations
11.
Pankratz, Susann, Niklas Huntemann, Lars Masanneck, et al.. (2021). Platelet Inhibition by Low-Dose Acetylsalicylic Acid Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis. International Journal of Molecular Sciences. 22(18). 9915–9915. 6 indexed citations
12.
Huntemann, Niklas, et al.. (2021). An optimized and validated protocol for inducing chronic experimental autoimmune encephalomyelitis in C57BL/6J mice. Journal of Neuroscience Methods. 367. 109443–109443. 10 indexed citations
13.
Mowforth, Oliver, Benjamin M. Davies, Alice Willison, et al.. (2020). Current provision of myelopathy education in medical schools in the UK: protocol for a national medical student survey. BMJ Open. 10(8). e035563–e035563. 2 indexed citations
14.
Birch, Joanna L., Barry J. Coull, Lindsay C. Spender, et al.. (2020). Multifaceted transforming growth factor-beta (TGFβ) signalling in glioblastoma. Cellular Signalling. 72. 109638–109638. 32 indexed citations
15.
Willison, Alice, et al.. (2020). A scoping review of trials for cell-based therapies in human spinal cord injury. Spinal Cord. 58(8). 844–856. 24 indexed citations
16.
Lindsay, Susan L., et al.. (2020). Multi-target approaches to CNS repair: olfactory mucosa-derived cells and heparan sulfates. Nature Reviews Neurology. 16(4). 229–240. 54 indexed citations
17.
Willison, Alice, et al.. (2016). All Patients with Diabetes Should Have Annual UACR Tests. Why is That So Hard?. BMJ Quality Improvement Reports. 5(1). u209185.w3747–u209185.w3747. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026